|Bid||8.55 x 800|
|Ask||8.56 x 3200|
|Day's Range||8.42 - 8.63|
|52 Week Range||8.01 - 17.32|
|Beta (3Y Monthly)||1.29|
|PE Ratio (TTM)||27.64|
|Earnings Date||Aug 6, 2019 - Aug 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||9.50|
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Free HIV tests will be available across the country to spread awareness for National HIV Testing Day on June 27. BETHLEHEM, Pa., June 26, 2019 (GLOBE NEWSWIRE) -- National HIV Testing Day will be commemorated on June 27 across the nation with efforts to raise awareness of HIV and encourage people to get tested and know their HIV status. OraSure Technologies, Inc. (OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, is joining with multiple organizations to offer free HIV testing across the country in support of National HIV Testing Day.
For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more...
When OraSure Technologies, Inc. (NASDAQ:OSUR) released its most recent earnings update (31 March 2019), I wanted to...
BETHLEHEM, Pa., June 14, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and.
BETHLEHEM, Pa., June 13, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Mr..
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]
OraSure Technologies, Inc. (NASDAQ:OSUR), which is in the medical equipment business, and is based in United States...
BETHLEHEM, Pa., May 29, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr..
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...
BETHLEHEM, Pa., May 15, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr..
OraSure Technologies, Inc. (OSUR), announced that its 2019 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019. In order to access the meeting, a stockholder or a person holding a valid stockholder proxy may go to www.virtualshareholdermeeting.com/OSUR2019 five (5) minutes prior to the start of the meeting to log in. A stockholder must enter the control number that was provided in the Notice Regarding the Availability of Proxy Materials, proxy card or other proxy materials received by such stockholder in order to vote and ask questions that are germane to the business being discussed at the meeting. A replay of the webcast will be available 24 hours after the meeting is concluded and will be archived on OraSure Technologies' website for seven days.
OraSure (OSUR) delivered earnings and revenue surprises of 16.67% and 1.42%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Bethlehem, Pennsylvania-based company said it had a loss of 5 cents. The diagnostic test maker posted revenue of $30.1 million in the period. OraSure shares have dropped 17% since ...
BETHLEHEM, Pa., May 08, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its.
"We are excited to get these clearances from the FDA," said Sam Niedbala, PhD and CEO of CryoConcepts, LP. "CryoTouch™ and CryoLab® have been designed to address user needs in a product category that has not seen innovation in over two decades. Our new, patent pending, products will deliver greater efficacy and are much easier-to-use. Portable devices such as the Histofreezer® and Verrucae Freeze® that are disposable can-like devices used by Pediatricians and General Practitioners.
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their opinion towards a company. This time it may be different. During the fourth quarter of 2018 we observed increased volatility and small-cap stocks underperformed the market. Hedge […]
OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! In this article we are going to estimate the intrinsic value of OraSure Technologies, Inc. (NASDAQ:OS...
CoreBiome, a microbiome discovery services provider and wholly-owned subsidiary of OraSure Technologies, Inc. (OSUR), announced today that Rob Knight, Professor and Director of the Center for Microbiome Innovation at the University of California San Diego, has joined its scientific advisory board. As an investigator on the National Institutes of Health Human Microbiome Project and a co-founder of the American Gut Project, Dr. Knight is one of the world’s leading microbiome researchers. “We are thrilled to have Rob Knight joining CoreBiome as a scientific advisor.
BETHLEHEM, Pa., April 17, 2019 -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 first quarter financial results,.
Since OraSure Technologies, Inc. (NASDAQ:OSUR) released its earnings in December 2018, it seems that analyst expectations are fairly bearish, with profits predicted to rise by...
By buying an index fund, investors can approximate the average market return. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return.Read More...